J. Vuillez

发表

Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.

P. Fumoleau, J. Chatal, F. Dubois, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma

F. Borson‐Chazot, F. Kraeber-Bodéré, J. Chatal, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Radioiodine therapy in benign thyroid disorders. Evaluation of French nuclear medicine practices.

B. Allenet, D. Fagret, M. Desruet, 2014, Annales d'endocrinologie.

Reduction of renal uptake of 111In‐DOTA‐labeled and A700‐labeled RAFT‐RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging

L. Sancey, D. Boturyn, P. Dumy, 2012, Cancer science.

Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement

F. Borson‐Chazot, F. Kraeber-Bodéré, S. Bardet, 2012, The Journal of Nuclear Medicine.

Comparison of three commercial kits and a microbiological assay for the determination of vitamin B12 in serum.

G. Ville, J. Arnaud, A. Favier, 1994, Scandinavian journal of clinical and laboratory investigation.

High levels of circulating IL‐10 in human malaria

J. Banchereau, P. Ringwald, N. Burdin, 1994, Clinical and experimental immunology.

Intrapleural infusion of activated macrophages and gamma-interferon in malignant pleural mesothelioma: a phase II study.

J. Breau, D. Moro, H. Léna, 2002, Chest.

Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.

V. Rohmer, F. Kraeber-Bodéré, S. Bardet, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pulmonary Scintigraphy for the Diagnosis of Acute Pulmonary Embolism: A Survey of Current Practices in Australia, Canada, and France

R. Hicks, M. Hofman, P. Salaun, 2015, The Journal of Nuclear Medicine.

Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.

G. Ferretti, E. Brambilla, C. Brambilla, 1994, European journal of cancer.

Adjuvant Intraarterial Lipiodol or 131I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial

E. Decullier, J. Dumortier, C. Létoublon, 2014, The Journal of Nuclear Medicine.

High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer.

B. Dupas, F. Kraeber-Bodéré, S. Bardet, 2005, The Journal of clinical endocrinology and metabolism.

18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.

L. Riou, J. Vuillez, L. Djaileb, 2018, Clinical nuclear medicine.

Intraoperative and Postoperative Gamma Detection of Somatostatin Receptors in Bone-invasive en Plaque Meningiomas

O. Palombi, E. Gay, J. Passagia, 2005, Neurosurgery.

Can tumour marker assays be a guide in the prescription of bone scan for breast and lung cancers?

D. Fagret, A. Gauchez, J. Vuillez, 1999, European Journal of Nuclear Medicine.

Correlative imaging study in the diagnosis of ovarian cancer recurrences

J. Chatal, J. Liehn, J. Dutin, 2004, European Journal of Nuclear Medicine.

Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro.

P. Ambroise‐Thomas, B. Polack, S. Picot, 1991, The Journal of infectious diseases.

FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the European Union

M. Zanca, J. Talbot, F. Montravers, 2007 .

Removal of circulating tumor necrosis factor. Its role in septic shock treatment.

B. Janbon, J. Vuillez, M. Guignier, 1992, Annales de medecine interne.

Cellular uptake of 99mTcN-NOET in human leukaemic HL-60 cells is related to calcium channel activation and cell proliferation

R. Pasqualini, E. Fontaine, D. Fagret, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.

F. Kraeber-Bodéré, A. Devillers, J. Chatal, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism.

P. Ambroise‐Thomas, S. Picot, F. Peyron, 1993, Immunology.

Targeted radionuclide therapy with RAFT-RGD radiolabelled with 90Y or 177Lu in a mouse model of αvβ3-expressing tumours

P. Perret, D. Boturyn, A. Broisat, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Optimal treatment of painful bone metastases with Samarium EDTMP in a haemodialysis patient: effectiveness and safety of internal radiotherapy.

M. Desruet, J. Vuillez, J. Caravel, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey

N. Magné, Cyrus Chargari, R. Mirimanoff, 2011, Supportive Care in Cancer.

In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors.

O. Chabre, D. Fagret, J. Vuillez, 1999, Clinical nuclear medicine.

Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum

P. Ambroise‐Thomas, K. Marsh, S. Picot, 1990, Infection and immunity.

Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody

J. Chatal, C. Curtet, J. Vuillez, 2004, European Journal of Nuclear Medicine.

Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC125) specific for CA125 antigen

P. Fumoleau, J. Chatal, J. Liehn, 1993 .

Development and Validation of Analytical Methods for Radiochemical Purity of 177Lu-PSMA-1

P. Bedouch, M. Desruet, J. Vuillez, 2022, Pharmaceuticals.

Long term management of essential mixed cryoglobulinemia

P. Vialtel, F. Bayle, D. Cordonnier, 1986 .

Plasma levels of tumor necrosis factor during a longitudinal survey in an endemic area of malaria.

P. Ambroise‐Thomas, S. Picot, F. Peyron, 1990, Acta tropica.

Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years

J. Dumortier, O. Guillaud, J. Scoazec, 2017, Annals of Nuclear Medicine.

Remission of Merkel cell tumor after somatostatin analog treatment.

J. Lebeau, M. Fakiha, J. Vuillez, 2010, Journal of cancer research and therapeutics.

CEA, CYFRA21-1 and SCC in non-small cell lung cancer.

C. Brambilla, D. Moro, J P Vuillez, 1995, Lung cancer.

Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.

D Huglo, D. Huglo, S. Bardet, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.

M. Colonna, J. Lebeau, D. Corcella, 2007, European journal of dermatology : EJD.

Study of inter- and intra-observer reproducibility in the interpretation of [18F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment

H. Boulahdour, D. Fagret, C. Caoduro, 2014, EJNMMI Research.

FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy

J. Perrot, F. Cachin, M. Leccia, 2021, Scientific Reports.

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.

R. Houot, B. Branger, T. Fest, 2018, Blood.

Levels of cytokines in plasma during Plasmodium falciparum malaria attacks

J. Le bras, P. Ringwald, P. Deloron, 1991, Journal of clinical microbiology.

Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial.

I. Soubeyran, P. Moreau, R. Gressin, 2017, The Lancet. Haematology.

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90y-Epratuzumab Tetraxetan Following R-CHOP in Elderly DLBCL Patients: A Lysa Phase II Prospective Trial

P. Moreau, R. Gressin, E. Deconinck, 2012 .

Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.

J. Chatal, J. Saccavini, J. Vuillez, 1992, The Journal of clinical endocrinology and metabolism.

Sera of patients with high titers of immunoglobulin G against Toxoplasma gondii induce secretion of tumor necrosis factor alpha by human monocytes

P. Ambroise‐Thomas, B. Polack, H. Pelloux, 1992, Infection and immunity.

Fluorinated tracers for imaging cancer with positron emission tomography

André Luxen, Roland Hustinx, Jean-Philippe Vuillez, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.

Jacques Barbet, Ludovic Ferrer, Caroline Rousseau, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial.

J. Douillard, P. Moreau, D. Moro, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.

M Bardiès, F. Kraeber-Bodéré, S. Bardet, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pretargeting with the affinity enhancement system for radioimmunotherapy.

F. Kraeber-Bodéré, E. Gautherot, J. Chatal, 1999, Cancer biotherapy & radiopharmaceuticals.

Influence of metabolic disturbances of diabetes mellitus on serum CA 19-9 tumor marker.

S. Halimi, P. Benhamou, I. Bachelot, 1991, Diabete & metabolisme.

In vivo imaging of tumour angiogenesis in mice with the αvβ3 integrin-targeted tracer 99mTc-RAFT-RGD

L. Sancey, D. Boturyn, P. Dumy, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum

P. Ambroise‐Thomas, K. Marsh, S. Picot, 1990, Infection and immunity.

Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.

F. Borson‐Chazot, F. Kraeber-Bodéré, S. Bardet, 2007, The Journal of clinical endocrinology and metabolism.

Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model.

L. Sancey, D. Boturyn, P. Dumy, 2008, Cancer biotherapy & radiopharmaceuticals.

Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?

J. Long, L. Riou, M. Laramas, 2020, Cancer Imaging.

Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?

M. Bolla, D. Fagret, M. Desruet, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX Plus 125IUdR

S. Adelstein, A. Kassis, D. Fagret, 2008, International journal of radiation biology.

18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours

D. Le Bars, M. Janier, V. Hervieu, 2011, Nuclear medicine communications.

Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies

J. Chatal, J. Saccavini, P. Lehur, 2004, European Journal of Nuclear Medicine.

Potential use of radiolabeled antisense oligonucleotides in oncology.

D. Fagret, J. Lunardi, A. Gauchez, 1999, Anticancer research.

Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.

E. Brambilla, C. Brambilla, P. Brichon, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Infection with Toxoplasma gondii does not Alter TNFα and IL-6 Secretion by A human Astrocytoma Cell Line

P. Ambroise‐Thomas, J. Renversez, H. Pelloux, 1994, Mediators of inflammation.

Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients.

F. Kraeber-Bodéré, M. Bardiès, J. Pouget, 2013, Immunotherapy.

Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 Treatment

J. Perrot, F. Cachin, M. Leccia, 2022, Diagnostics.

Ring‐infected erythrocyte surface antigen (Pf/155RESA) induces tumour necrosis factor‐alpha production

P. Ambroise‐Thomas, P. Deloron, S. Picot, 1993, Clinical and experimental immunology.

In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.

L. Sancey, D. Boturyn, P. Dumy, 2007, European journal of nuclear medicine and molecular imaging.

Adjuvant Intraarterial Lipiodol or 131I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial

E. Decullier, J. Dumortier, C. Létoublon, 2014, The Journal of Nuclear Medicine.